Evidence map›Paper›PMID 30441786›Full record

ArticleViruses2018

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management.

Antonin Bal, Clémentine Sarkozy, Laurence Josset, Valérie Cheynet, Guy Oriol, Jérémie Becker, Gaëlle Vilchez, Pierre Sesques, François Mallet, Alexandre Pachot and 6 more

Abstract read
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Rapid diagnosis ofFrontiers in medicine · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Deep sequencing applied to the analysis of viromes in patients with beta-thalassemia.Revista do Instituto de Medicina Tropical de Sao Paulo · 2021
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Antonin BalLaboratoire de Virologie, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69004 Lyon, France. antonin.bal@chu-lyon.fr.
Clémentine SarkozyService d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, 69495 Lyon, France. clementine.sarkozy@chu-lyon.fr.
Laurence JossetLaboratoire de Virologie, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69004 Lyon, France. laurence.josset@chu-lyon.fr.ORCID 0000-0002-7158-1186
Valérie CheynetLaboratoire Commun de Recherche HCL-bioMerieux, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France. valerie.cheynet@biomerieux.com.
Guy OriolLaboratoire Commun de Recherche HCL-bioMerieux, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France. guy.oriol@biomerieux.com.
Jérémie BeckerBioaster, Genomics and Transcriptomics Technological Unit, 69007 Lyon, France. jeremie.becker@bioaster.org.
Gaëlle VilchezLaboratoire Commun de Recherche HCL-bioMerieux, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France. gaelle.vilchez@ext.biomerieux.com.
Pierre SesquesService d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, 69495 Lyon, France. pierre.sesques@chu-lyon.fr.
François MalletLaboratoire Commun de Recherche HCL-bioMerieux, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France. francois.mallet@biomerieux.com.
Alexandre PachotLaboratoire Commun de Recherche HCL-bioMerieux, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France. alexandre.pachot@biomerieux.com.
Florence MorfinLaboratoire de Virologie, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69004 Lyon, France. florence.morfin-sherpa@chu-lyon.fr.
Bruno LinaLaboratoire de Virologie, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, 69004 Lyon, France. bruno.lina@chu-lyon.fr.
Gilles SallesService d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, 69495 Lyon, France. gilles.salles@chu-lyon.fr.ORCID 0000-0002-9541-8666
Fréderic ReynierBioaster, Genomics and Transcriptomics Technological Unit, 69007 Lyon, France. frederic.reynier@bioaster.org.
Sophie Trouillet-AssantUniv Lyon, Université Lyon 1, Faculté de Médecine Lyon Est, CIRI, Inserm U1111 CNRS UMR5308, Virpath, 69372 Lyon, France. sophie.assant@chu-lyon.fr.
Karen Brengel-PesceLaboratoire Commun de Recherche HCL-bioMerieux, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France. karen.brengel-pesce@biomerieux.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over recent years, there has been increasing interest in the use of the anelloviruses, the major component of the human virome, for the prediction of post-transplant complications such as severe infections. Due to an important diversity, the comprehensive characterization of this viral family over time has been poorly studied. To overcome this challenge, we used a metagenomic next-generation sequencing (mNGS) approach with the aim of determining the individual anellovirus profile of autologous stem cell transplant (ASCT) patients. We conducted a prospective pilot study on a homogeneous patient cohort regarding the chemotherapy regimens that included 10 ASCT recipients. A validated viral mNGS workflow was used on 108 plasma samples collected at 11 time points from diagnosis to 90 days post-transplantation. A complex interindividual variability in terms of abundance and composition was noticed. In particular, a strong sex effect was found and confirmed using quantitative PCR targeting torque teno virus, the most abundant anellovirus. Interestingly, an important turnover in the anellovirus composition was observed during the course of the disease revealing a strong intra-individual variability. Although more studies are needed to better understand anellovirus dynamics, these findings are of prime importance for their future use as biomarkers of immune competence.

Indexed as

Genetic VariationStem Cell TransplantationTransplantation, AutologousTransplant RecipientsAnelloviridaeAntineoplastic AgentsBloodDNA, ViralDNA Virus InfectionsDrug TherapyHigh-Throughput Nucleotide SequencingHumansMultiple MyelomaPilot ProjectsProspective StudiesSequence Analysis, DNAAntineoplastic AgentsDNA, ViralAnelloviridaeimmunocompromised patientsnext-generation sequencingstem cell transplant recipientstorque teno virusviral metagenomics

Identifiers

PMID30441786
PMCPMC6266913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.